Angiotensinogen gene M235T polymorphism and risk of coronary artery disease: A meta-analysis

Molecular Medicine Reports

Volumn 6, Issue 4, 2012, Pages 884-888

  Wang, Yu Jing ^a   Pan, Yan ^a  

^a YANGTZE UNIVERSITY   (China)

Author keywords

Angiotensinogen gene; Chinese; Coronary artery disease; Meta analysis; Polymorphism

Indexed keywords

ANGIOTENSINOGEN;

ARTICLE; CARDIOVASCULAR RISK; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DNA POLYMORPHISM; GENETIC ASSOCIATION; GENETIC RISK; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; RISK ASSESSMENT; SYSTEMATIC REVIEW;

ANGIOTENSINOGEN; CORONARY ARTERY DISEASE; DATABASES, FACTUAL; HETEROZYGOTE; HOMOZYGOTE; HUMANS; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84865178101     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2012.1011     Document Type: Article

References (23)

1. Negi S and Anand A: Atherosclerotic coronary heart disease-epidemiology, classification and management. Cardiovasc Hematol Disord Drug Targets 10: 257-261, 2010.
2. Moran A, Gu D, Zhao D, et al: Future cardiovascular disease in China: Markov model and risk factor scenario projections from the coronary heart disease policy model - China. Circ Cardiovasc Qual and Outcomes 3: 243-252, 2010.
3. Xu MQ, Ye Z, Hu FB and He L: Quantitative assessment of the effect of angiotensinogen gene polymorphisms on the risk of coronary heart disease. Circulation 116: 1356-1366, 2007. (Pubitemid 47417561)
4. Zafarmand MH, van der Schouw YT, Grobbee DE, et al: The M235T polymorphism in the AGT gene and CHD risk: evidence of a Hardy-Weinberg equilibrium violation and publication bias in a meta-analysis. PLoS One 3: e2533, 2008.
5. Chen D, Liu JL, Liu Y, et al: Lack of an association between -308G>A polymorphism of the TNF-α gene and liver cirrhosis risk based on a meta-analysis. Genet Mol Res 10: 2765-2774, 2011.
6. Mantel N and Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748, 1959.
7. DerSimonian R and Laird N. Meta-analysis in clinical trials. Control Clin Trials 7: 177-188, 1986. (Pubitemid 17189972)
8. Egger M, Davey Smith G, Schneider M and Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 315: 629-634, 1997. (Pubitemid 27387172)
9. Ko YL, Ko YS, Wang SM, et al: Angiotensinogen and angiotensin-I converting enzyme gene polymorphisms and the risk of coronary artery disease in Chinese. Hum Genet 100: 210-214, 1997.
10. Chen D, Zhang M, Fan W, et al: A molecular variant of angio-tensinogen gene is associated with myocardial infarction in Chinese. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 15: 133-135, 1998 (In Chinese).
11. Sheu WH, Lee WJ, Jeng CY, et al: Angiotensinogen gene polymorphism is associated with insulin resistance in nondiabetic men with or without coronary heart disease. Am Heart J 136: 125-131, 1998. (Pubitemid 28317877)
12. Xie Y, Zhang FM, Ma WZ, et al: Association between gene polymorphism of renin-angiotensin system and coronary heart disease. Nanjing Yi Ke Da Xue Xue Bao 21: 488-491, 2001 (In Chinese).
13. Zhu TB, Xu W, Yang ZJ, et al: Association analysis of three polymorphism of renin-angiotensin system genes with coronary heart disease. Jiangsu Med J 28: 745-746, 2002 (In Chinese).
14. Gu WD, Zhu JH, Pan M, et al: Effects of angiotensinogen and apolipoprotein E gene polymorphisms on coronary heart disease. Nan Tong Yi Xue Yuan Xue Bao 23: 394-395, 2003 (In Chinese).
15. Zhu TN, Pan JQ, Shen ZJ, et al: Gene polymorphisms of reninangiotensin system and coronary thrombosis disease. Zhongguo Shi Yan Xue Ye Xue Za Zhi 12: 674-679, 2004 (In Chinese).
16. Li L, Fan XH, Zhang YW, et al: Association between angiotensinogen gene polymorphism and severity of coronary artery stenosis. J Med Forum 25: 12-14, 2004 (In Chinese).
17. Ren J, Jia YP, Lv JY and Guo XH: Relationship between angiotensinogen gene M235T polymorphism and coronary heart disease. J Shanxi Med Univ 36: 439-442, 2005 (In Chinese).
18. Zhang XH, Lu ZL and Liu L: Coronary heart disease in China. Heart 94: 1126-1131, 2008.
19. Critchley J, Liu J, Zhao D, et al: Explaining the increase in coronary heart disease mortality in Beijing between 1984 and 1999. Circulation 110: 1236-1244, 2004. (Pubitemid 39202339)
20. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al: Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169-180, 1992.
21. Henrion D, Kubis N and Lévy BI: Physiological and pathophysiological functions of the AT(2) subtype receptor of angiotensin II: from large arteries to the microcirculation. Hypertension 38: 1150-1157, 2001. (Pubitemid 34252821)
22. Horiuchi M, Akishita M and Dzau VJ: Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 33: 613-21, 1999. (Pubitemid 29091636)
23. Dietz R, von Harsdorf R, Gross M, et al: Angiotensin II and coronary artery disease, congestive heart failure, and sudden cardiac death. Basic Res Cardiol 93: 101-108, 1998. (Pubitemid 28498139)